RGS2 drives male aggression in mice via the serotonergic system von Mark, Melanie D., Wollenweber, Patric, Gesk, Annika, Kösters, Katja, Batzke, Katharina, Janoschka, Claudia, Maejima, Takashi, Han, Jing, Deneris, Evan S., Herlitze, Stefan

Volltext

The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models von Pajtler, Kristian W, Sadowski, Natalie, Ackermann, Sandra, Althoff, Kristina, Schönbeck, Kerstin, Batzke, Katharina, Schäfers, Simon, Odersky, Andrea, Heukamp, Lukas, Astrahantseff, Kathy, Künkele, Annette, Deubzer, Hedwig E, Schramm, Alexander, Sprüssel, Annika, Thor, Theresa, Lindner, Sven, Eggert, Angelika, Fischer, Matthias, Schulte, Johannes H

Volltext

TrkB-Target Galectin-1 Impairs Immune Activation and Radiation Responses in Neuroblastoma: Implications for Tumour Therapy von Batzke, Katharina, Büchel, Gabriele, Hansen, Wiebke, Schramm, Alexander

Volltext

Case Report of Anti-Thrombogenicity von Boedecker-Lips, Simone C., Batzke, Katharina, Klimpke, Pascal, Holtz, Stefan, Kraus, Daniel, Weinmann-Menke, Julia

Volltext

Immune response modulation by Galectin-1 in a transgenic model of neuroblastoma von Büchel, Gabriele, Schulte, Johannes H., Harrison, Luke, Batzke, Katharina, Schüller, Ulrich, Hansen, Wiebke, Schramm, Alexander

Volltext

RGS2 drives male aggression in mice via the serotonergic system von Mark, Melanie D, Wollenweber, Patric, Gesk, Annika, Kösters, Katja, Batzke, Katharina, Janoschka, Claudia, Maejima, Takashi, Han, Jing, Deneris, Evan S, Herlitze, Stefan

Volltext